Table 3.

Multivariate analysis of relevant parameters and disease-free survival for high-risk stage II patients

	HR	95% CI limits
CMS 1	a
CMS 2	0.225	0.053–0.957
CMS 3	0.599	0.062–5.781
CMS 4	Reference
Gender	2.725	0.488–15.225
Age	0.986	0.952–1.022
Location	3.45	0.799–14.85
T	2.006	0.360–11.173
MSI	b

CMS Consensus molecular subtype, MSI Microsatellite instability

^aNot estimable due to no events

^bNot estimable due to no MSI patients